Free tools, free alerts. Create a free account to get sector-matched alerts and save your searches.
Create free account →
2026-09-22

Regulatory Watch

AI-synthesized intelligence from CBN, FIRS, CAC, NAFDAC, SON, and NEPZA — so your business stays ahead of regulatory change.

September 22, 2026 8 updates 2 sources
Recent NAFDAC actions signal tighter enforcement on drug and food product quality, with new blacklistings, watchlist alerts, and mandatory clinical trial training for stakeholders. The inauguration of a Pharmacist Reserve Group and high-level conference on pharmaceutical innovation point to a push for local production capacity and regulatory compliance. For Nigerian SMBs in pharmaceuticals, healthcare, and related distribution, this means increased scrutiny and a need to verify supplier and product legitimacy.
What's being regulated
Pharmaceuticals Healthcare Food and Drug Distribution Import/Export Clinical Research
Latest regulatory changes
NAFDAC Blacklists Ayrtons Saunders Ltd, UK
NAFDAC
NAFDAC has blacklisted Ayrtons Saunders Ltd, UK, and its products, warning the public, healthcare institutions, and importers to avoid them.
SMBs importing or distributing products from this company must immediately cease and verify their supply chains to avoid regulatory penalties.
NAFDAC Places Mofus Nigeria Ltd Products on Watchlist
NAFDAC
NAFDAC has placed products marketed by Mofus Nigeria Ltd on a watchlist pending regulatory investigation, alerting healthcare professionals and distributors.
Retailers and distributors should quarantine these products and await further directives to avoid compliance breaches.
NAFDAC and NHREC Announce New Dates for Mandatory Clinical Trial Regulations Training
NAFDAC
NAFDAC and NHREC have set new dates for mandatory stakeholder training on clinical trial regulations in Nigeria.
SMBs involved in clinical research or trials must ensure their staff attend this training to remain compliant with regulatory requirements.
Inauguration of NAFDAC Pharmacist Reserve Group
NAFDAC
NAFDAC inaugurated a Pharmacist Reserve Group of 600 pharmacists to provide voluntary service, enhancing regulatory oversight and support.
This may lead to increased inspections and support for SMBs in pharmaceuticals, requiring better compliance readiness.
NAFDAC DG Address at Chemical Society of Nigeria Conference
NAFDAC
The NAFDAC DG highlighted innovations in medicinal and pharmaceutical chemistry for affordable healthcare delivery.
SMBs in pharmaceutical manufacturing and research should align with these innovation trends to remain competitive and compliant.
Regulatory and Supervisory Guidelines for Bureau De Change Operations in Nigeria 2024
Other
New regulatory and supervisory guidelines for Bureau De Change operations in Nigeria were published.
SMBs in the financial services sector, particularly BDC operators, must review and comply with these guidelines to avoid sanctions.
NDLEA, NAFDAC Exempted from Dissolution of FG Parastatals Boards
NAFDAC
NDLEA and NAFDAC were exempted from the dissolution of boards of federal government parastatals, ensuring continuity in their regulatory functions.
This provides stability in NAFDAC's operations, meaning SMBs can expect consistent regulatory enforcement and engagement.
How to Register Your Fish Farm with NEPC Nigeria: A Complete Export Guide
Other
A guide on registering fish farms with NEPC for export purposes was published.
SMBs in aquaculture and fish farming can leverage this guide to access export markets and ensure compliance with NEPC requirements.
What this means for your business
Increased regulatory scrutiny on pharmaceutical and food product imports and distribution.
Mandatory training for clinical trial stakeholders indicates stricter oversight in research.
NAFDAC's Pharmacist Reserve Group may lead to more frequent inspections and support.
Emphasis on local pharmaceutical innovation could create opportunities for SMBs in manufacturing.
BDC operators face new guidelines, requiring operational adjustments.
NEPC registration guide opens export opportunities for fish farmers.
What to do next
1 Verify all suppliers and products against NAFDAC blacklists and watchlists.
2 Register for and attend the mandatory NAFDAC/NHREC clinical trial regulations training if involved in clinical research.
3 Review and align operations with the new BDC guidelines if applicable.
4 Ensure staff are aware of NAFDAC alerts and maintain proper documentation for inspections.
5 Consider NEPC registration for fish farm exports to access new markets.
6 Stay updated with NAFDAC communications and adjust supply chains accordingly.
← Previous edition
Browse archive
Next edition →

Never miss a regulatory change

From CBN monetary policy to FIRS tax circulars — our AI Workspace monitors the regulatory landscape so you don't have to.

Create free account